ROVI presented its ISM® technology platform at the meeting of the Innovation Committee of the Institute for the Development and Integration of Healthcare (IDIS Foundation). The debate was attended by Pedro Carretero Trillo, Director of Hospitals and Institutional Relations; Ibon Gutierro Adúriz, Director of R&D, and Javier Martínez González, Medical Director.
Throughout the colloquium, a presentation was made showing the advances throughout history in relation to long-acting injectables and the importance of achieving a reduction in symptomatology as quickly as oral treatment. In this sense, the results of ISM® Technology, designed to combine the sequential effect of three different mechanisms to control the release of active ingredients, were highlighted, as it provides therapeutic levels as fast as oral medication and maintains them in a sustained and predictable way.